Medpace Holdings Raises FY2026 GAAP EPS Guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 Est; Raises FY2026 Sales Guidance from $2.755

Medpace Holdings (NASDAQ: MEDP ) raises FY2026 GAAP EPS guidance from $16.68-$17.50 to $17.25-$17.95 vs $16.97 analyst estimate. Raises FY2026 sales outlook from $2.755 billion-$2.855 billion to $2.805 billion-$2.885 billion vs $2.778 billion estimate.